• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人乳头瘤病毒相关疾病免疫预防专家共识]

[Expert consensus on immunological prevention of human papillomavirus-related diseases].

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Aug 6;53(8):761-803. doi: 10.3760/cma.j.issn.0253-9624.2019.08.001.

DOI:10.3760/cma.j.issn.0253-9624.2019.08.001
PMID:31378039
Abstract

Human papillomavirus (HPV)-related diseases such as cervical cancer have become a public health problem that seriously threatens human health. In response to the action plan for the elimination of cervical cancer, this consensus, on the basis of the World Health Organization position paper on HPV vaccine (2017) and the latest advances in research at home and abroad, provides an overview of HPV pathogens and the clinical, epidemiological and vaccine aspects of HPV related diseases. Through a comprehensive and systematic introduction of HPV disease-related knowledge, we aim to improve the level of prevention and control of HPV related diseases, especially to provide systematic and comprehensive evidence-based basis for professionals to use HPV vaccine scientificly.

摘要

宫颈癌等与人乳头瘤病毒(HPV)相关的疾病已成为严重威胁人类健康的公共卫生问题。为响应消除宫颈癌行动计划,本共识基于世界卫生组织关于HPV疫苗的立场文件(2017年)以及国内外最新研究进展,概述了HPV病原体以及HPV相关疾病的临床、流行病学和疫苗方面的情况。通过全面系统地介绍HPV疾病相关知识,我们旨在提高HPV相关疾病的防控水平,尤其为专业人员科学使用HPV疫苗提供系统全面的循证依据。

相似文献

1
[Expert consensus on immunological prevention of human papillomavirus-related diseases].[人乳头瘤病毒相关疾病免疫预防专家共识]
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Aug 6;53(8):761-803. doi: 10.3760/cma.j.issn.0253-9624.2019.08.001.
2
[Expert consensus on immunological prevention of human papillomavirus-related diseases (abridged)].人乳头瘤病毒相关疾病免疫预防专家共识(节略版)
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1499-1516. doi: 10.3760/cma.j.issn.0254-6450.2019.12.002.
3
[Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].人乳头瘤病毒相关疾病免疫预防专家共识(节略版)
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1218-1235. doi: 10.3760/cma.j.issn.0253-9624.2019.12.006.
4
[Human papillomavirus infection and vaccination].[人乳头瘤病毒感染与疫苗接种]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):106-112. doi: 10.3760/cma.j.issn.0253-9624.2018.01.021.
5
Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.美国男女性生殖器人乳头瘤病毒感染率和疫苗接种率的差异。
Future Oncol. 2017 Jun;13(13):1129-1132. doi: 10.2217/fon-2017-0147. Epub 2017 Jun 7.
6
HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.南非的人乳头瘤病毒疫苗接种:抗击宫颈癌的一剂希望之针。
Cancer Cytopathol. 2016 Oct;124(10):695-698. doi: 10.1002/cncy.21738. Epub 2016 May 16.
7
[AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].[人乳头瘤病毒相关疾病、宫颈癌及预防性人乳头瘤病毒(HPV)疫苗]
Akush Ginekol (Sofiia). 2015;54 Suppl 1:25-31.
8
Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).预防人免疫缺陷病毒(HIV)感染者的人乳头瘤病毒(HPV)相关肿瘤。
Expert Rev Anti Infect Ther. 2017 Nov;15(11):987-999. doi: 10.1080/14787210.2017.1392854. Epub 2017 Oct 20.
9
Knowledge of cervical cancer and the HPV vaccine.宫颈癌及人乳头瘤病毒疫苗知识
Br J Nurs. 2006;15(3):126-7. doi: 10.12968/bjon.2006.15.3.20506.
10
Prevention strategies of cervical cancer in the HPV vaccine era.人乳头瘤病毒疫苗时代的宫颈癌预防策略
Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17.

引用本文的文献

1
Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases.中国女性人乳头瘤病毒感染的患病率、趋势及地理分布:2728321例病例的汇总分析
BMC Med. 2025 Mar 13;23(1):158. doi: 10.1186/s12916-025-03975-6.
2
Are HPV Vaccines Well Accepted among Parents of Adolescent Girls in China? Trends, Obstacles, and Practical Implications for Further Interventions: A Five-Year Follow-Up Study.人乳头瘤病毒疫苗在中国青春期女孩家长中接受程度如何?趋势、障碍及进一步干预的实际意义:一项五年随访研究
Vaccines (Basel). 2024 Sep 19;12(9):1073. doi: 10.3390/vaccines12091073.
3
Opportunities and challenges for human papillomavirus vaccination in China.
中国 HPV 疫苗接种的机遇与挑战。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2329450. doi: 10.1080/21645515.2024.2329450. Epub 2024 Apr 4.
4
Clinical significance of MATN1-AS1 as ceRNA of Mir-200b in tissues and serum of patients with cervical cancer.MATN1-AS1 在宫颈癌组织和血清中的 ceRNA 作用及其对 Mir-200b 的调控作用
Sci Rep. 2023 Sep 15;13(1):15336. doi: 10.1038/s41598-023-42023-2.
5
The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer.多种人乳头瘤病毒(HPV)感染与宫颈癌发生、发展及预后之间的相关性。
Front Microbiol. 2023 Jul 28;14:1220522. doi: 10.3389/fmicb.2023.1220522. eCollection 2023.
6
Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis.预防性人乳头瘤病毒疫苗对亚洲人群宫颈癌的疗效:一项荟萃分析。
Front Microbiol. 2022 Dec 2;13:1052324. doi: 10.3389/fmicb.2022.1052324. eCollection 2022.
7
Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.消除宫颈癌:在中国推广人乳头瘤病毒疫苗面临的挑战
Indian J Gynecol Oncol. 2021;19(3):51. doi: 10.1007/s40944-021-00536-6. Epub 2021 Jun 27.
8
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.通过定制优化路径消除宫颈癌的有效性和成本效益:建模研究。
BMC Med. 2021 Mar 3;19(1):62. doi: 10.1186/s12916-021-01930-9.